Skip to Main Content

Paper Details

Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study.
Blood Adv
3
2023
Author NameAffiliation
Patricia KropfNovant Health Cancer Institute - Elizabeth
Jean-Pierre J IssaCoriell Institute for Medical Research
Hagop KantarjianThe University of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2